Exact Sciences
EXAS
#1382
Rank
NZ$21.15 B
Marketcap
$114.49
Share price
2.34%
Change (1 day)
-9.41%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of June 2024 : NZ$10.78 B

According to Exact Sciences's latest financial reports the company's total assets are NZ$10.78 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$10.23 B4.34%
2022-12-31NZ$9.80 B0.48%
2021-12-31NZ$9.76 B42.54%
2020-12-31NZ$6.84 B31.77%
2019-12-31NZ$5.19 B128.85%
2018-12-31NZ$2.27 B169.46%
2017-12-31NZ$0.84 B54.84%
2016-12-31NZ$0.54 B2.22%
2015-12-31NZ$0.53 B33.53%
2014-12-31NZ$0.39 B123.36%
2013-12-31NZ$0.17 B30.55%
2012-12-31NZ$0.13 B10.09%
2011-12-31NZ$0.12 B-1.1%
2010-12-31NZ$0.12 B251.42%
2009-12-31NZ$35.74 M249.6%
2008-12-31NZ$10.22 M-45.87%
2007-12-31NZ$18.88 M-44.25%
2006-12-31NZ$33.87 M-38.81%
2005-12-31NZ$55.36 M-29.59%
2004-12-31NZ$78.63 M47.39%
2003-12-31NZ$53.35 M-44.25%
2002-12-31NZ$95.7 M-37.02%
2001-12-31NZ$0.15 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$1.75 B-83.74%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.99 B-81.50%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$35.72 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$224.82 B 1,984.35%๐Ÿ‡ซ๐Ÿ‡ท France